VulnerabilityModified
CVE-2022-22834
An authenticated user who has the Test Trasformazione XSL functionality enabled can exploit a XSLT Injection vulnerability.
HIGH 8.8EPSS 3.49%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (3.49%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An issue was discovered in OverIT Geocall before 8.0. An authenticated user who has the Test Trasformazione XSL functionality enabled can exploit a XSLT Injection vulnerability. Attackers could exploit this issue to achieve remote code execution.
- CVSS 3.1
- 8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 3.49% probability · 88th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-91
- Affected
- overit/geocall
- Source
- cve@mitre.org
References
- https://labs.yarix.com/2022/03/overit-framework-xslt-injection-and-xxe-cve-2022-22834-cve-2022-22835/Exploit, Third Party Advisory
- https://labs.yarix.com/advisories/cve-2022-22834/Third Party Advisory
- https://overit.us/products/geocall/Product, Vendor Advisory
- https://www.overit.ai/product/nextgen-fsm/
- https://labs.yarix.com/2022/03/overit-framework-xslt-injection-and-xxe-cve-2022-22834-cve-2022-22835/Exploit, Third Party Advisory
- https://labs.yarix.com/advisories/cve-2022-22834/Third Party Advisory
- https://overit.us/products/geocall/Product, Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.